Researchers from MIT, in collaboration with the Broad Institute of MIT and Harvard and Massachusetts General Hospital, have introduced a new artificial intelligence (AI) tool known as Tyche, which can provide multiple, plausible image segmentation possibilities for a given medical image. Unlike conventional AI tools, which typically offer a single definitive interpretation, Tyche generates a…
Biomedicine often requires the annotation of pixels in a medical image to identify critical structures such as organs or cells, a process known as segmentation. In this context, artificial intelligence (AI) models can be useful to clinicians by highlighting pixels indicating potential disease or anomalies. However, decision-making in medical image segmentation is frequently complex, with…
MIT researchers, using deep learning techniques, have discovered compounds that can effectively combat methicillin-resistant Staphylococcus aureus (MRSA). This drug-resistant bacterium annually leads to over 10,000 deaths in the United States alone. Detailed in a study published in Nature, the compounds not only successfully killed MRSA in laboratory and mice model tests, but also showed significantly…
MIT researchers have leveraged the power of deep learning, a branch of artificial intelligence (AI), to discover a class of compounds that can potentially kill methicillin-resistant Staphylococcus aureus (MRSA). The discovery, described in a paper published in the journal Nature, saw the use of AI to predict the antibiotic potency of various molecules, an insight…
At MIT, a team of researchers is utilizing deep learning—a type of artificial intelligence—to discover new, potentially life-saving antibiotics. Their focus is on combating one of the world's deadliest drug-resistant bacterium: methicillin-resistant Staphylococcus aureus (MRSA), which takes over 10,000 lives in America annually.
Published in Nature, MIT's study reveals that a new class of compounds, identified…
MIT researchers utilize Artificial Intelligence to discover a new category of potential antibiotics.
Utilizing deep learning, researchers from the Massachusetts Institute of Technology (MIT) have identified a new class of compounds that effectively kill methicillin-resistant Staphylococcus aureus (MRSA), a drug-resistant bacterium responsible for over 10,000 deaths each year in the United States. The compounds have been found to have low toxicity against human cells, a key characteristic for…
Using deep learning, a form of artificial intelligence, MIT researchers have identified a new class of compounds capable of killing methicillin-resistant Staphylococcus aureus (MRSA), a drug-resistant bacterium responsible for over 10,000 deaths annually in the United States. The findings were published in the journal Nature.
The compounds exhibited strong activity against MRSA in lab conditions…
Researchers from MIT have employed deep learning artificial intelligence (AI) to discover a set of compounds capable of exterminating methicillin-resistant Staphylococcus aureus (MRSA), a drug-resistant bacterium causing over 10,000 deaths annually in the U.S. Published in Nature, the study highlights that these compounds can kill MRSA both in a lab and in two MRSA mouse…
Researchers from MIT have utilized deep learning, a form of artificial intelligence, to find a class of compounds that can kill drug-resistant bacteria, specifically methicillin-resistant Staphylococcus aureus (MRSA). The significance of their research is that these compounds have low toxicity against human cells, making them suitable candidates for therapeutic drugs.
Crucially, the researchers can understand the…